That is necessary, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be effective. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (jeff brown biotech genome sequencing). But now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. This was a breakthrough nearly nobody observed. But it's going to have profound implications for treating illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (future report review). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly considerably prior to going higher - bleeding edge. I've been covering bitcoin for a long time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. However that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of terrific private business on the edge of striking the general public markets And I have actually been dealing with a new way for you to invest even before these business go public.
This opportunity has been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to schedule your area for free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our normal beat (biotech stock). And when it concerns tech investing, we leave it to the specialists. Luckily, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we understand (black sea). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid development and developing extraordinary opportunities for financiers. I desire to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. tech predictions. However despite what lots of readers might think, this is a pattern that's just beginning. Although the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown 1 biotech company). Losing 2 months of manufacturing and sales really impacts the number of 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million units is remarkable. More notably, the hold-ups triggered by the pandemic created a lots of pent-up need. Which demand is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - black sea. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually described its 3 different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services begin to be used (melania trump). That's when we start to see applications running on 5G networks. Think about things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summertime. This begins something of a virtuous cycle: The majority of people do not truly care about the technology. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities going forward will be enormous. Stepping away from 5G, the next essential technology I visualize in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche technology that wasn't well understood. And throughout that time, there were truly only 3 business operating in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This whole industry is successfully a greenfield opportunity.
There's space for many companies to exist in this area. angel investor. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or 3 more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can accurately predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is essential since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced using this innovation. This was among those advancements that practically no one noticed. However it's going to have extensive ramifications for treating illness. And, obviously, there will be plenty of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back possibly substantially prior to going higher. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - melania trump. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. jeff brown prediction for 2021. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date since February 2021, however we could not individually validate this claim. Provided Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent viewpoint on the marketplace. He's always on the hunt for new chances, and he shares a number of his best picks in the Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he effectively anticipated some of the greatest financial occasions of the previous 20 years. Although he does not appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it best whenever, however Jeff Brown's accurate predictions have made him legions of devoted fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research uses numerous research study services with a variety of specializations - jeff brown.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - jeff bezos. On its website, Brownstone says its mission is to supply retail investors with professional-grade research: "For too long, the finest investment research has actually not been offered to private investors. It has been generally scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown prediction for 2021. The objective of Brownstone Research is to make that type of proprietary research study offered to any financiers wanting to acquire an edge in the marketplaces. The objective is easy to deliver distinct and profitable investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also functions as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a little bit about the market, you know that he has a reputation as a King Midas of sorts. black sea. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown thinks S.A.V. bleeding edge. might be "the biggest trend of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding 2 innovative innovations: artificial intelligence and electric cars and trucks. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing except the automobile market's Holy Grail. As you know, electric cars and self-driving vehicle stocks have been substantial this year, however the Wall Street maker has approved hype without much concrete result. Despite a drastic increase in competitors over the previous few years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech might be the magic string that connects everything together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transportation. Basically, this innovation would permit you to lease out your car as an autonomous, self-driving taxi when you're not utilizing it. You just leave the vehicle and press a button on an app that tells the car to "join the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the profits. It sounds ridiculous, but it might be closed than you believe.